SB-742457 And Donepezil In Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2006

Conditions
Alzheimer's Disease
Interventions
DRUG

SB-742457

DRUG

donepezil

Trial Locations (26)

1113

GSK Investigational Site, Sofia

1431

GSK Investigational Site, Sofia

9010

GSK Investigational Site, Varna

10617

GSK Investigational Site, Tallinn

28832

GSK Investigational Site, Achim

35625

GSK Investigational Site, Hüttenberg

45525

GSK Investigational Site, Hattingen

51014

GSK Investigational Site, Tartu

52499

GSK Investigational Site, Baesweiler

73760

GSK Investigational Site, Ostfildern

115552

GSK Investigational Site, Moscow

117049

GSK Investigational Site, Moscow

197022

GSK Investigational Site, Saint Petersburg

198103

GSK Investigational Site, Saint Petersburg

2352499

GSK Investigational Site, Valparaíso

7500710

GSK Investigational Site, Providencia / Santiago

7560356

GSK Investigational Site, Santiago

A-6060

GSK Investigational Site, Hall in Tirol

A-1130

GSK Investigational Site, Vienna

A-1220

GSK Investigational Site, Vienna

811 01

GSK Investigational Site, Bratislava

826 06

GSK Investigational Site, Bratislava

831 03

GSK Investigational Site, Bratislava

BD7 1HR

GSK Investigational Site, Bradford

SN1 4HZ

GSK Investigational Site, Swindon

G20 0XA

GSK Investigational Site, West of Scotland Science Park, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY